Carnegie Investment Counsel 13F: Adds $1.5M to PG Stake
Key Points
- Carnegie Investment Counsel added 10,855 shares of The Procter & Gamble Company to grow its stake by 4.3% to 263,261 shares valued at about $36.8 million.
- The Procter & Gamble Company reported trailing-twelve-month revenue of $87.0 billion alongside an earnings per share of $6.62.
- Other institutional investors adjusted their holdings, while insider transactions included shares sold by Chief Financial Officer Andre Schulten.
Since the filing, $PG is down 1.5% to date (from the $159.32 close on Oct 20, 2026).
Get The Procter & Gamble Company text alerts
We text you when insiders, Congress, analysts or big funds move on $PG.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated The Procter & Gamble Company alert may contain errors. Disclosures
Carnegie Investment Counsel boosted its stake in The Procter & Gamble Company (NYSE:PG) by 4.3% during the quarter, purchasing an additional 10,855 shares to bring its total holding to 263,261 shares. According to a Form 13F filing disclosed on October 20, 2026, the value of the firm's position reached approximately $36.8 million.
Carnegie Investment Counsel vs. the S&P 500
Hypothetical returns from Carnegie Investment Counsel's disclosed trades, not real profit or advice. How we model this.
What Changed in Carnegie Investment Counsel's Procter & Gamble Position
The adjustment increased the firm's investment from its previous count of 252,406 shares. The reported value of the position at the time of the filing reflects the broader valuation of the consumer goods maker.
Other Institutional Activity in The Procter & Gamble Company
Other fund managers also adjusted their positions in the household products company. Bell Bank reduced its holdings by 20,955 shares, ending with 51,763 shares worth about $7.5 million. PensionDanmark Pensionsforsikringsaktieselskab grew its holdings by 30,957 shares, ending with 489,542 shares worth about $71.1 million. Meanwhile, Cantor Fitzgerald Investment Advisors L.P. sold out of its position by shedding 5,078 shares.
The Procter & Gamble Company Stock Holds Steady
The stock closed at $159.32 on October 20, 2026, and recently traded around $157.71 as of October 22, 2026. The shares trade above both their 50-day and 200-day moving averages while sitting below their 52-week high of $167.25.
Recent Earnings
The Procter & Gamble Company reported trailing-twelve-month revenue of $87.0 billion and an earnings per share of $6.62. The company posted a net profit margin of 18.4% and a return on equity of 30.3%.
Dividend
The company distributes an annual dividend rate of $4.35 per share, translating to a dividend yield of 2.76% with a payout ratio of 64.3%.
Insider Buying and Selling at The Procter & Gamble Company
Company insiders executed trades prior to the filing date. Chief Financial Officer Andre Schulten sold 3,914 shares on October 5, 2026. Officer Susan Street Whaley sold 2,369 shares, and officer Paul Gama sold 2,225 shares on the same date.
Analysts Set New Price Targets
Wall Street firms updated their views on the stock ahead of the filing. On September 30, 2026, TD Cowen maintained a hold rating with a $150.00 price target. Evercore ISI Group upgraded the stock to an outperform rating and lifted its target to $166.00 on October 6, 2026. RBC Capital maintained an outperform rating with a $166.00 target on the same day, while Citigroup maintained a buy rating with a $180.00 target on October 14, 2026. RBC Capital later reiterated its outperform rating on October 20, 2026. The stock carries a consensus buy rating and a mean price target of $162.13 across 23 analyst opinions.
About The Procter & Gamble Company
Headquartered in Cincinnati, Ohio, The Procter & Gamble Company manufactures and sells branded consumer packaged goods across five main segments: beauty, grooming, health care, fabric and home care, and baby, feminine and family care.
Bottom Line
Institutional investors continue to fine-tune their stakes in consumer defensive giants like Procter & Gamble. Market participants will monitor subsequent filings and upcoming financial reports for further shifts in institutional ownership.
Source: Carnegie Investment Counsel's 13F filing on $PG (Oct 20, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts